Hematopoietic Stem Cells in Type 1 Diabetes

Despite the increasing knowledge of pathophysiological mechanisms underlying the onset of type 1 diabetes (T1D), the quest for therapeutic options capable of delaying/reverting the diseases is still ongoing. Among all strategies currently tested in T1D, the use of hematopoietic stem cell (HSC)-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastore, Ida, Assi, Emma, Ben Nasr, Moufida, Bolla, Andrea Mario, Maestroni, Anna, Usuelli, Vera, Loretelli, Cristian, Seelam, Andy Joe, Abdelsalam, Ahmed, Zuccotti, Gian Vincenzo, D’Addio, Francesca, Fiorina, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299361/
https://www.ncbi.nlm.nih.gov/pubmed/34305929
http://dx.doi.org/10.3389/fimmu.2021.694118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299361/
https://www.ncbi.nlm.nih.gov/pubmed/34305929
http://dx.doi.org/10.3389/fimmu.2021.694118

Ejemplares similares